UBS Group's stake in Jiangsu Hengrui Pharmaceuticals falls to 4.59%

UBS Group AG's long position in the H-shares of Jiangsu Hengrui Pharmaceuticals Co. Ltd. has decreased to 4.59%, according to a filing with the Hong Kong Stock Exchange (HKEX).